Leonardo Italia

TL;DR: This case report describes an otherwise healthy 53-year-old woman who tested positive for CO VID-19 and was admitted to the cardiac care unit in March 2020 for acute myopericarditis with systolic dysfunction, confirmed on cardiac magnetic resonance imaging, the week after onset of fever and dry cough due to COVID-19.

TL;DR: Hospitalized patients with concomitant cardiac disease and COVID-19 have an extremely poor prognosis compared with subjects without a history of cardiac disease, with higher mortality, thrombo-embolic events, and septic shock rates.

TL;DR: Recent data show the lack of untoward effects of ACE inhibitors or angiotensin receptor blockers for COVID‐19 infection and severity, and Prospective trials are needed to ascertain whether these drugs may have protective effects.

TL;DR: A close and intriguing relationship has been suggested between heart failure (HF) and coronavirus disease 2019 (COVID-19) as mentioned in this paper, leading to a subsequent increase in heart failure mortality.

TL;DR: The COVID-19 pandemic had a significant impact on the STEMI care system reducing hospital admissions and prolonging revascularization time, which translated into a worse patient prognosis due to more STEMI complications.